Résumé
Les tumeurs malignes de la vulve touchent 1,9/100000 femmes/an et représentent 3–5% des cancers gynécologiques [1–3]. L’âge moyen de 47 patientes, que nous avons traitées à Lausanne entre 1971 et 1986, est de 75 ans. Si l’on se réfère à la littérature, les patientes souffrant d’un carcinome épidermoïde ont 70 ans et plus, alors que celles qui présentent un mélanome ou un sarcome ont respectivement 55 ans et 42 ans [1,2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Références
Castano-Almendral A, Torhorst J (1988) Tumoren der Vulva. In: Gynäkologie und Geburtshilfe. Thieme, Stuttgart
Brinton LA, Nasca PC, Maliin K, Baptiste MS, Wilbanks GD, Richart RM (1990) Case-control study of cancer of the vulva. Obstet Gynecol 75:859–866
Mabuchi K, Bross DS, Kessler II (1985) Epidemiology of cancer of the vulva. A case-control study. Cancer 55:1843–1848
Syrjänen KJ (1984) Current concepts of human papillomavirus infection in the genital tract and their relationship to intra-epithelial and squamous cell carcinoma. Obstet Gynecol Surv 39:252–265
Sutton GP, Stehman FB, Ehrlich CE, Roman A (1987) Human papillomavirus deoxyribonucleic acid in lesions of the female genital tract: evidence for type 6/11 in squamous carcinoma of the vulva. Obstet Gynecol 70:564–568
Gupka J, Pilotti S, Rilke F, Shah K (1987) Association of human papillomavirus type 16 with neoplastic lesion of the vulva and other genital sites by in situ hybridization. Am J Pathol 127:206–215
Koutsky LA, Galloway DA, Holmes KK (1988) Epidemiology of genital human papillomavirus infection. Epidemiol Rev 10:122–163
Buscema J, Naghshfar Z, Sawada E, Daniel R, Woodruff D, Shah K (1988) The predominance of human papillomavirus type 16 in vulvar neoplasia. Obstet Gynecol 71:601–606
Carson LF, Twiggs LB, Okagati T, Clark BA, Ostrow RS, Faras AJ (1988) Human papillomavirus DNA in adenosquamous carcinoma and squamous cell carcinoma of the vulva. Obstet Gynecol 72:63–67
Podratz KC, Symmonds RE, Taylor WF, Williams TJ (1983) Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 61:63–74
Baird PJ (1978) A pathological study of the relationship between lichen sclerosus et atrophicus and squamous carcinoma of the vulva. Pathology 10:196
Dontenwille MN, Pelisse M, Moyal M, Lessana-Leibowitch M (1984) Carcinome épidermoïde invasif de la vulve et lichen scléreux. Proc. Journées dermatologiques, Paris 8–10 mars 1984
Baltzer J. (1988) Präkanzerosen und Frühstadien des Vulvakarzinoms. Arch Gynecol Obstet 245:498–503
Meyhöfer W (1981) Kraurosis vulvae-kraurosis penis et praeputii-Lichen sclerosus et atrophicus. In: Dermatologie in Praxis und Klinik. Thieme, Stuttgart
Lejarcegui JA, Puig-Tintore LM (1981) Distrofias de la vulva. In: Gonzales-Merlo J (ed) Diagnostica precoz del Cancer Genital Feminino. Salvat Editores, Barcelona
Heberling D, Döhnert G, Rummel HH (1979) Karzinom der apokrinen Vulvadrüsen mit vorwiegend epidermaler Ausbreitung unter dem Bilde des invasiv wachsenden Morbus Paget. Geburtsh Frauenheilkd 39:101–105
Remberger K (1986) Histologie und Ausbreitung der invasiven Vulvakarzinome. In: Erkrankungen der Vulva. Urban & Schwarzenberg, München
Patsner B, Mann WJ (1989) Serum squamous cell carcinoma antigen levels in patients with invasive squamous vulvar and vaginal cancer: a preliminary report. Gynecol Oncol, pp 323–325
van der Sijde R, de Bruijn HWA, Krans M, Aalders JG (1989) Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva. Gynecol Oncol 35:227–232
Wilkinson EJ, Rico MJ, Pierson KK (1982) Microinvasive carcinoma of the vulva. Int J Gynecol Pathol 1:29–39
Di Paola G (1991) Management of the vulvar cancer. 7th International Meeting of Gynaecolo-gic Oncology and 1st World Convention of Oncologic Gynecology. Venice, April 14–18,1991
Kürzl R, Baltzer J, Lohe KJ (1986) Prognostische Bedeutung histologischer Merkmale beim Vulvakarzinome. In: Erkrankungen der Vulva. Urban & Schwarzenberg, München
Binder SW, Huang I, Fu YS, Hacker NF, Berek JS (1990) Risk factors for the development of lymph node metastasis in vulvar squamous cell carcinoma. Gynecol Oncol 37:9–16
Husseinzadeh N, Wesseler T, Schneider D, Schellhas H, Nahhas W (1990) Prognostic factors and the significance of cytologic grading in invasive squamous cell carcinoma of the vulva: a clinico-pathological study. Gynecol Oncol 36:192–199
Zucker PK, Berkowitz RS (1985) The issue of microinvasive squamous cell carcinoma of the vulva: an evaluation of criteria of diagnosis and methods of therapy. Obstet Gynecol Surv 40:136–143
Ross MJ, Ehrmann RL (1987) Histologic prognosticators in stage I squamous cell carcinoma of the vulva. Obstet Gynecol 70:774–784
Burrell MO, Franklin EW III, Campion MJ, Crozier MA, Stacy DW (1988) The modified radical vulvectomy with groin dissection: an eight-year experience. Am J Obstet Gynecol 159:715–722
Hoffman MS, Roberts WS, LaPolla JP, Cavanagh D (1989) Recent modifications in the treatment of invasive squamous cell carcinoma of the vulva. Obstet Gynecol Surv 44:227–233
Lupi G (1991) Pre-surgical Chemo-Radiotherapy in vulvar cancer. 7th International Meeting of Gynaecologic Oncology and 1st World Convention of Oncologic Gynecology. Venice, April 14–18,1991
Sevin BU, Homesley HD (1986) Das Vulvakarzinom. Gynäkologe 19:109–115
Iversen T, Aalders JG, Christensen A, Kolstad P (1980) Squamous cell carcinoma of the vulva. A review of 424 patients, 1956–1974. Gynecol Oncol 9:271–279
Lupi G, Baeli A, Delaloye JF (1989) Value of lymphadenectomy in cancer of the vulva. ESGO 6, Versailles, April 27–29,1989
Bender HG (1989) Derzeitige Therapie des Vulvakarzinoms. Ergebnisse einer Umfrage an den deutschen Universitäts-Frauenkliniken. Arch Gynecol Obstet 245:513–517
Goldberg MI, Rothfleisch MD (1981) The tensor fascia lata mycocutaneous flap in gynecologic oncology. Gynecol Oncol 12:41–50
Beck L, Bender HG (1981) Musc, gracilis zur Deckung von Defekten in Vagina und Vulva. Gynäkologe 14:49–52
Knapstein PG, Mahlke M, Poleska W, Zeuner W (1989) Operative Behandlung des Vulvakarzinoms und plastische Deckung von Vulva-Defekten. Arch Gynecol Obstet 245:504–511
Hohlweg-Majert P (1989) Plastische Deckung von großen Vulvadefekten mittels myocutaner Lappenplastik. Arch Gynecol Obstet 245:512–513
Pao WM, Perez CA, Kuske RR, Sommers GM, Camel HM, Galakatos AE (1988) Int J Radiat Oncol Biol Phys 14:1123–1132
Slevin NJ, Pointon RCS (1989) Radical radiotherapy for carcinoma of the vulva. Br J Radiol 62:145–147
Hoffman M, Greenberg S, Greenberg H, Fiorica JV, Roberts WS, LaPolla JP, Noriega BK, Cavanagh D (1990) Interstitial radiotherapy for the treatment of advanced or recurrent vulvar and distal vaginal malignancy. Am J Obstet Gynecol 162:1278–1282
Boronow RC (1982) Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer. Cancer 49: 1085–1091
Rotmensch J, Rubin SJ, Sutton HG, Javaheri G, Halpern HJ, Schwartz JL, Stewart M, Weichselbaum RR, Herbst AL (1990) Preoperative radiotherapy followed by radical vulvectomy with inguinal lymphadenectomy for advanced vulvar carcinomas. Gynecol Oncol 36:181 – 184
Pfleiderer A (1986) Zytostatische Therapie des Vulvarkarcinoms. In: Erkrankungen der Vulva. Urban & Schwarzenberg, München
Thomas G, Dembo A, De Petrillo A, Pringle J, Ackerman I, Bryson P, Balogh J, Osborne R, Rosen B, Fyles A (1989) Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 34:263–267
Chambers SK, Flynn SD, Del Prête SA, Chambers JT, Schwartz PE (1989) Bleomycin, Vincristine, Mitomycine-C and cis-Platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity. Gynecol Oncol 32:303–309
Weghaupt K (1986) Vulvakarzinom-Elektroresektion und Elektrokoagulation der Vulva (Wiener Methode). In: Erkrankungen der Vulva. Urban & Schwarzenberg, München
Andersen ES, Sorensen IM (1988) Verrucous carcinoma of the female genital tract: report of a case and review of the literature. Gynecol Oncol 30:427–734
Podratz KC, Gaffey TA, Symmonds RE, Johansen KL, O’Brien PC (1983) Melanoma of the vulva: an update. Gynecol Oncol, pp 153–168
Bradgate MG, Rollason TP, Mc Conkey CC, Powell J (1990) Malignant melanoma of the vulva: a clinical-pathological study of 50 women. Br J Obstet Gynaecol 97:124–133
Beller U, Demopoulos RI, Beckman EM (1986) Vulvovaginal melanoma: a clinicopathological study. J Reprod Med 31:315–319
Davidson T, Kissin M, Westbury G (1987) Vulvovaginal melanoma: should radical surgery be abandoned? Br J Obstet Gynaecol 94:473–476
Brand E, Fu YS, Lagasse LD, Berek JS (1989) Vulvovaginal melanoma: report of seven cases and literature review. Gynecol Oncol 33:54–60
Creagan ET, Cupps RE, Ivans JS Prichard DJ, Sim FH, Soule EH, O’Fallon JR (1978) Adjuvant radiation therapy for regional node metastases from malignant melanoma. Cancer 42:2206–2210
Pettersson F (1985) Annual report on the results of treatment in gynecological cancer, vol. 19. Trycheri Balder AB, Stockholm
Hopkins MP, Reid GC, Morley GW (1990) The surgical management of recurrent squamous cell carcinoma of the vulva. Obstet Gynecol 75:1001–1005
Knapstein PG, Güldutuna S, Mitze M, Weikel W (1991) Posterior exenteration for advanced or recurrent vulvar carcinoma. Eur J Gynaecol Oncol 12:273
Magrina JF (1991) Revised classification of pelvic exenteration. 7th International Meeting of Gynaecologic Oncology and 1st World Convention of Oncologic Gynecology. Venice, April 14–18,1991
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Delaloye, J.F., de Grandi, P. (1991). Les cancers de la vulve. In: Verhandlungen der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe. Archives of Gynecology and Obstetrics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-37811-3_13
Download citation
DOI: https://doi.org/10.1007/978-3-662-37811-3_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-37103-9
Online ISBN: 978-3-662-37811-3
eBook Packages: Springer Book Archive